IL1B and depressive symptom measurement: Interestingly, one of the mechanisms of antidepressant treatment may involve reductions in microglial activation and serum levels of IL-1β, suggesting that pro-inflammatory cytokines can be used as a potential targets in the treatment of depression (45–47).